Measures involving colony observation      


Select table page: First Prev 1 - 10 / 152 (152) Next Last
    Access protocols via the Procedure column.
Sort/
Pick
Data set
Procedure / Protocol
Treatment
Phenotype Measure / Variable (click to view)
Panel
No. of Strains
Sex
Age
Sample Size (Avg)
Year
Ankra-Badu1 colony observation (none) fraternal litter size at day 12 after birth   [n]  DAY12   21201 QTL population both 2wks N=502 2009
    Attie2 colony observation high-fat high-sucrose diet number of days on diet   [n]  diet_days   110631     DO population both 4-26wks N=242 2018
    Bennett2 colony observation (none) mouse appearance description   [designation]  appearance   36901 categorical ILSXISS f 2005
Brockmann1 colony observation (none) number of offspring per litter: 3 classes   [n]  pupsize   21301 QTL population both 6wks N=138 2009
Brockmann1 colony observation (none) number of offspring per litter: 5 classes   [n]  pupsize_b   21501 QTL population both 6wks N=201 2009
    Chang1 colony observation (none) animal age at test (local parameter)   [wks]  age   15720 inbred 17 both N=15 2008
    Chesler2 colony observation (none) number of mice born in first litter   [n]  litter_size   43441     CC diallel w/par 62 both 4wks N=8 2011
    Chesler2 colony observation (none) parental age at first litter   [d]  age_first_litter   43442     CC diallel w/par 62 both 4wks N=8 2011
    Chesler2 colony observation (none) time from mate to first litter   [d]  duration_to_litter   43443     CC diallel w/par 62 both 4wks N=8 2011
    Chesler3 colony observation (none) number of mice born in first litter   [n]  litter_size   43541 CC pre w/par 312 both 4wks N=2 2011
    All boxes             To see more rows use the paging control at top.






Other available data sets:
Data set Procedure What's in this data set Panel Sex Age (weeks) Year
ITP1 colony observation
with (R/S)-1,3-butanediol, 17-a-estradiol, 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride, 2-(2-Hydroxyphenyl)benzoxazole, 3-(3-hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one, 4-OH-a-phenyl-N-tert-butyl nitrone, 4-phenylbutyrate, acarbose, aspirin, astaxanthin, b-guanidinopropionic acid, caffeic acid phenethyl ester, canagliflozin, captopril, candesartan cilexetil, curcumin, dimethyl fumarate, enalapril, fisetin, fish oil, geranylgeranyl acetone, glycine, green tea extract, INT-767 FXR/TGR5 agonist, inulin, L-Leucine, meclizine, medium-chain triglyceride, metformin, metformin plus rapamycin, methylene blue, minocycline, MitoQ, mycophenolic acid, nicotinamide riboside, nitroflurbiprofen, nordihydroguaiaretic acid, oxaloacetic acid, PB125, protandim, rapamycin, rapamycin plus acarbose, resveratrol, SG1002, simvastatin, sulindac, syringaresinol, TM5441, ursodeoxycholic acid, ursolic acid, 16-a-hydroxyestriol, 2,4-dinitrophenol, a-Ketoglutarate, Hydralazine, Nebivolol, Sodium thiosulfate
Life span study. Various interventions vs. controls. UM-HET3 population both various 2004-2024